FOXP3 and colorectal carcinoma: To explore the immune response against tumors in CRC model mice, we performed immunohistochemical analysis (IHC) to analyze the Foxp3, CD8, and Granzyme B (Fig. 8A) expression after therapy; this was quantified as the number of positive cells divided by total cells in the tumor microenvironment.